ndc,moud_med,proprietary_name,strength,dosage_form,route,appl_no,labeler_name,product_ndc,nonproprietary_name,substance_name,product_type_name,start_marketing_date,end_marketing_date,market_category,package_description,pharm_class,dea,sample_package,listing_record_certified_through,check,strength_clean
65757030001,nal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
59385002160,bup,BELBUCA,75 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-021,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-021-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-021-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,0.075
59385002260,bup,BELBUCA,150 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-022,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-022-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-022-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,0.15
59385002360,bup,BELBUCA,300 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-023,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-023-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-023-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,0.3
59385002460,bup,BELBUCA,450 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-024,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/21/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-024-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-024-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,0.45
59385002560,bup,BELBUCA,600 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-025,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-025-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-025-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,0.6
59385002660,bup,BELBUCA,750 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-026,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-026-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-026-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,0.75
59385002760,bup,BELBUCA,900 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-027,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/11/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-027-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-027-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,0.9
12496075705,bup,Buprenex,.3 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA018401,Indivior Inc.,12496-0757,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/1985,N/A,NDA,5 AMPULE in 1 CARTON (12496-0757-5)  / 1 mL in 1 AMPULE (12496-0757-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335095002,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0950-2),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
42858058640,bup,Buprenorphine,15 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-586,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-586-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335095004,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,7 TABLET in 1 BOTTLE (71335-0950-4),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
62756045983,bup,Buprenorphine,2 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-459,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (62756-459-83),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
62756046083,bup,Buprenorphine,8 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-460,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (62756-460-83),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335095008,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0950-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
00093365740,bup,Buprenorphine,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3657,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3657-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00228315303,bup,Buprenorphine,8 mg/1,TABLET,SUBLINGUAL,ANDA090819,"Actavis Pharma, Inc.",0228-3153,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/10/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (0228-3153-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
00228315603,bup,Buprenorphine,2 mg/1,TABLET,SUBLINGUAL,ANDA090819,"Actavis Pharma, Inc.",0228-3156,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/10/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (0228-3156-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
42858050103,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Rhodes Pharmaceuticals L.P.,42858-501,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (42858-501-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
62756045964,bup,Buprenorphine,2 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-459,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,3 BLISTER PACK in 1 CARTON (62756-459-64)  / 10 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
71335095005,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-0950-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
71335095007,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-0950-7),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
71335115400,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1154-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115401,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1154-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115402,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1154-2),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115403,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1154-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115404,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1154-4),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115405,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/16/2020,N/A,ANDA,7 TABLET in 1 BOTTLE (71335-1154-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115406,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/28/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1154-6),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115407,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,1 TABLET in 1 BOTTLE (71335-1154-7),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115408,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-1154-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335115409,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,14 TABLET in 1 BOTTLE (71335-1154-9),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
62756046064,bup,Buprenorphine,8 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-460,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,3 BLISTER PACK in 1 CARTON (62756-460-64)  / 10 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
58118050108,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,"Clinical Solutions Wholesale, LLC",58118-0501,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2017,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0501-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
71335095006,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,1 TABLET in 1 BOTTLE (71335-0950-6),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
58118050208,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,"Clinical Solutions Wholesale, LLC",58118-0502,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2022,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0502-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
60687048121,bup,Buprenorphine,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,American Health Packaging,60687-481,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-481-21)  / 1 TABLET in 1 BLISTER PACK (60687-481-11)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
60687049221,bup,Buprenorphine,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,American Health Packaging,60687-492,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-492-21)  / 1 TABLET in 1 BLISTER PACK (60687-492-11)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
42858035340,bup,Buprenorphine,7.5 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-353,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-353-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
42858049340,bup,Buprenorphine,10 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-493,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-493-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
42858050203,bup,BUPRENORPHINE,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Rhodes Pharmaceuticals L.P.,42858-502,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (42858-502-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
42858083940,bup,Buprenorphine,20 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-839,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-839-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
42858075040,bup,Buprenorphine,5 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-750,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-750-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
00093365940,bup,Buprenorphine,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3659,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3659-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00093323940,bup,Buprenorphine,7.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3239,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,4 POUCH in 1 CARTON (0093-3239-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
63629947501,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,63629-9475,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-9475-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
71335095001,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0950-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
69238120202,bup,Buprenorphine,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1202,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1202-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
69238120302,bup,Buprenorphine,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1203,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1203-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
69238120402,bup,Buprenorphine,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1204,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1204-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
69238120502,bup,Buprenorphine,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1205,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1205-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
69238150502,bup,Buprenorphine,7.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1505,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1505-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335095003,bup,BUPRENORPHINE,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0950-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
00093365640,bup,Buprenorphine,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3656,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3656-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00093365840,bup,Buprenorphine,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3658,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3658-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
43598058030,bup,Buprenorphine and Naloxone,"4 mg/1,                         1  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205806,Dr.Reddys Laboratories Inc,43598-580,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-580-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-580-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00228315403,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA091422,"Actavis Pharma, Inc.",0228-3154,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,03/04/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (0228-3154-03),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00228315503,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA091422,"Actavis Pharma, Inc.",0228-3155,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,03/04/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (0228-3155-03),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
60687062665,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA205601,American Health Packaging,60687-626,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,11/01/2021,N/A,ANDA,50 BLISTER PACK in 1 CARTON (60687-626-65)  / 1 TABLET in 1 BLISTER PACK (60687-626-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00378876593,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA211785,Mylan Pharmaceuticals Inc.,0378-8765,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,04/17/2020,N/A,ANDA,30 POUCH in 1 CARTON (0378-8765-93)  / 1 FILM in 1 POUCH (0378-8765-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00378876693,bup,Buprenorphine and Naloxone,"4 mg/1,                         1  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA211785,Mylan Pharmaceuticals Inc.,0378-8766,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,04/17/2020,N/A,ANDA,30 POUCH in 1 CARTON (0378-8766-93)  / 1 FILM in 1 POUCH (0378-8766-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
70518312900,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA201633,REMEDYREPACK INC.,70518-3129,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,06/17/2021,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3129-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
43598057930,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205299,Dr.Reddys Laboratories Inc,43598-579,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-579-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-579-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
70518338900,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205601,REMEDYREPACK INC.,70518-3389,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,03/16/2022,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3389-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
70518360300,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA201633,REMEDYREPACK INC.,70518-3603,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,01/04/2023,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3603-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
00378876893,bup,Buprenorphine and Naloxone,"12 mg/1,                         3  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA207607,Mylan Pharmaceuticals Inc.,0378-8768,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/20/2019,N/A,ANDA,30 POUCH in 1 CARTON (0378-8768-93)  / 1 FILM in 1 POUCH (0378-8768-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
42858060103,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA205601,Rhodes Pharmaceuticals L.P.,42858-601,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,04/13/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (42858-601-03)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
42858060203,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205601,Rhodes Pharmaceuticals L.P.,42858-602,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,04/13/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (42858-602-03)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
62756097064,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA201633,"Sun Pharmaceutical Industries, Inc.",62756-970,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,07/18/2017,N/A,ANDA,3 BLISTER PACK in 1 CARTON (62756-970-64)  / 10 TABLET in 1 BLISTER PACK,"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
47781035503,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-355,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-355-03)  / 1 FILM in 1 POUCH (47781-355-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
47781035603,bup,Buprenorphine and Naloxone,"4 mg/1,                         1  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-356,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-356-03)  / 1 FILM in 1 POUCH (47781-356-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
47781035703,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-357,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-357-03)  / 1 FILM in 1 POUCH (47781-357-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
47781035803,bup,Buprenorphine and Naloxone,"12 mg/1,                         3  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-358,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-358-03)  / 1 FILM in 1 POUCH (47781-358-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137800,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,42 TABLET in 1 BOTTLE (71335-1378-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137801,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,10/25/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1378-1),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137802,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1378-2),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137803,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1378-3),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137804,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1378-4),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137805,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,14 TABLET in 1 BOTTLE (71335-1378-5),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137806,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1378-6),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137807,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,6 TABLET in 1 BOTTLE (71335-1378-7),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137808,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1378-8),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335137809,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1378,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/30/2022,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-1378-9),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
50383029493,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA204431,Akorn Operating Company LLC (dba Akorn),50383-294,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/07/2016,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (50383-294-93)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
62756096983,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA201633,"Sun Pharmaceutical Industries, Inc.",62756-969,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,07/18/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (62756-969-83),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
70518231100,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,REMEDYREPACK INC.,70518-2311,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,09/12/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2311-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
60429058730,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA204431,"Golden State Medical Supply, Inc.",60429-587,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/07/2016,09/30/2023,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (60429-587-30)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,N/A,0,NA
00378876793,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA207607,Mylan Pharmaceuticals Inc.,0378-8767,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/20/2019,N/A,ANDA,30 POUCH in 1 CARTON (0378-8767-93)  / 1 FILM in 1 POUCH (0378-8767-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
50383028793,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA204431,Akorn Operating Company LLC (dba Akorn),50383-287,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/07/2016,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (50383-287-93)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
60505705305,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA212756,Apotex Corp.,60505-7053,buprenorphine and naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,30 POUCH in 1 CARTON (60505-7053-5)  / 1 FILM in 1 POUCH (60505-7053-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
60505705405,bup,Buprenorphine and Naloxone,"12 mg/1,                         3  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA212756,Apotex Corp.,60505-7054,buprenorphine and naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,30 POUCH in 1 CARTON (60505-7054-5)  / 1 FILM in 1 POUCH (60505-7054-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
63629948201,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA205601,Bryant Ranch Prepack,63629-9482,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (63629-9482-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
63629948301,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205601,Bryant Ranch Prepack,63629-9483,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (63629-9483-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
43598058130,bup,Buprenorphine and Naloxone,"12 mg/1,                         3  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205806,Dr.Reddys Laboratories Inc,43598-581,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-581-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-581-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
62175045832,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205022,"Lannett Company, Inc.",62175-458,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,09/19/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (62175-458-32),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
60687063765,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA205601,American Health Packaging,60687-637,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,11/01/2021,N/A,ANDA,50 BLISTER PACK in 1 CARTON (60687-637-65)  / 1 TABLET in 1 BLISTER PACK (60687-637-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
70518348700,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA205601,REMEDYREPACK INC.,70518-3487,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,08/19/2022,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3487-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
43598058230,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205299,Dr.Reddys Laboratories Inc,43598-582,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-582-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-582-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
62756096964,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA201633,"Sun Pharmaceutical Industries, Inc.",62756-969,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,07/18/2017,N/A,ANDA,3 BLISTER PACK in 1 CARTON (62756-969-64)  / 10 TABLET in 1 BLISTER PACK,"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
62756097083,bup,Buprenorphine and Naloxone,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA201633,"Sun Pharmaceutical Industries, Inc.",62756-970,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,07/18/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (62756-970-83),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
62175045232,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA205022,"Lannett Company, Inc.",62175-452,Buprenorphine and Naloxone,BUPRENORPHINE;  NALOXONE,HUMAN PRESCRIPTION DRUG,09/19/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (62175-452-32),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335129601,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1296,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,08/12/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1296-1),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335129602,bup,Buprenorphine and Naloxone,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA205022,Bryant Ranch Prepack,71335-1296,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,06/29/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1296-2),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
70518201400,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2014,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/12/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2014-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
70518201401,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2014,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2021,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (70518-2014-1)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
68071291503,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,"NuCare Pharmaceuticals,Inc.",68071-2915,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-2915-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,1,8
00054017613,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,Hikma Pharmaceuticals USA Inc.,0054-0176,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (0054-0176-13),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
00054017713,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Hikma Pharmaceuticals USA Inc.,0054-0177,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (0054-0177-13),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
70518222600,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/19/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2226-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
70518222601,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (70518-2226-1)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
70518222602,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/04/2021,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (70518-2226-2)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
70518222603,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/04/2021,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (70518-2226-3)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
71335116300,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1163-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
00904715404,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,Major Pharmaceuticals,0904-7154,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0904-7154-04)  / 1 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
00904715504,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Major Pharmaceuticals,0904-7155,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0904-7155-04)  / 1 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
58118017608,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,"Clinical Solutions Wholesale, LLC",58118-0176,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2018,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0176-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
58118017708,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,"Clinical Solutions Wholesale, LLC",58118-0177,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2018,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0177-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116301,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/21/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1163-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116302,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/24/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1163-2),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116303,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1163-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116304,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1163-4),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116305,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,7 TABLET in 1 BOTTLE (71335-1163-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116306,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1163-6),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116307,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,1 TABLET in 1 BOTTLE (71335-1163-7),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116308,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-1163-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
71335116309,bup,Buprenorphine HCl,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,14 TABLET in 1 BOTTLE (71335-1163-9),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
55700030230,bup,Buprenorphine HCl,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,Lake Erie Medical DBA Quality Care Products LLC,55700-302,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-302-30),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
65162041503,bup,Buprenorphine HCl and Naloxone HCl,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA203136,Amneal Pharmaceuticals LLC,65162-415,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/22/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-415-03),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
50268014415,bup,Buprenorphine HCl and Naloxone HCl,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203136,AvPAK,50268-144,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,12/08/2016,N/A,ANDA,"50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-144-15)  / 1 TABLET in 1 BLISTER PACK (50268-144-11)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
50268014515,bup,Buprenorphine HCl and Naloxone HCl,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA203136,AvPAK,50268-145,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,12/08/2016,N/A,ANDA,"50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-145-15)  / 1 TABLET in 1 BLISTER PACK (50268-145-11)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
70518100700,bup,Buprenorphine HCl and Naloxone HCl,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203136,REMEDYREPACK INC.,70518-1007,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/08/2018,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-1007-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
65162041609,bup,Buprenorphine HCl and Naloxone HCl,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203136,Amneal Pharmaceuticals LLC,65162-416,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/22/2013,N/A,ANDA,90 TABLET in 1 BOTTLE (65162-416-09),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
63629726901,bup,Buprenorphine HCl and Naloxone HCl,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203136,Bryant Ranch Prepack,63629-7269,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,12/16/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-7269-1),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
65162041603,bup,Buprenorphine HCl and Naloxone HCl,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203136,Amneal Pharmaceuticals LLC,65162-416,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/22/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-416-03),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
65162041509,bup,Buprenorphine HCl and Naloxone HCl,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA203136,Amneal Pharmaceuticals LLC,65162-415,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/22/2013,N/A,ANDA,90 TABLET in 1 BOTTLE (65162-415-09),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335151401,bup,Buprenorphine HCl and Naloxone HCl,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203136,Bryant Ranch Prepack,71335-1514,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1514-1),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335151402,bup,Buprenorphine HCl and Naloxone HCl,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203136,Bryant Ranch Prepack,71335-1514,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/21/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1514-2),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00143924605,bup,Buprenorphine Hydrochloride,.324 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,ANDA076931,Hikma Pharmaceuticals USA Inc.,0143-9246,Buprenorphine Hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2019,N/A,ANDA,5 VIAL in 1 CARTON (0143-9246-05)  / 1 mL in 1 VIAL (0143-9246-01),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
42023017905,bup,Buprenorphine Hydrochloride,.324 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,ANDA206586,"Par Pharmaceutical, Inc.",42023-179,Buprenorphine Hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/30/2015,N/A,ANDA,5 VIAL in 1 CARTON (42023-179-05)  / 1 mL in 1 VIAL,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
50090157100,bup,buprenorphine hydrochloride,8 mg/1,TABLET,SUBLINGUAL,ANDA090622,A-S Medication Solutions,50090-1571,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (50090-1571-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,1,8
50383092493,bup,buprenorphine hydrochloride,2 mg/1,TABLET,SUBLINGUAL,ANDA090622,Akorn Operating Company LLC (dba Akorn),50383-924,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2010,N/A,ANDA,30 TABLET in 1 BOTTLE (50383-924-93),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,2
00409201232,bup,Buprenorphine Hydrochloride,.3 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA074137,"Hospira, Inc.",0409-2012,Buprenorphine Hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/14/2005,N/A,ANDA,10 CARTRIDGE in 1 CARTON (0409-2012-32)  / 1 mL in 1 CARTRIDGE (0409-2012-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
50383093093,bup,buprenorphine hydrochloride,8 mg/1,TABLET,SUBLINGUAL,ANDA090622,Akorn Operating Company LLC (dba Akorn),50383-930,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2010,N/A,ANDA,30 TABLET in 1 BOTTLE (50383-930-93),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,1,8
70518221600,bup,buprenorphine hydrochloride,2 mg/1,TABLET,SUBLINGUAL,ANDA090622,REMEDYREPACK INC.,70518-2216,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/15/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2216-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,1,2
71335185809,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"21 TABLET in 1 BOTTLE, PLASTIC (71335-1858-9)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335165301,bup,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203326,Bryant Ranch Prepack,71335-1653,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,10/29/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1653-1),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172001,bup,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203326,Bryant Ranch Prepack,71335-1720,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,10/19/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1720-1),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172002,bup,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203326,Bryant Ranch Prepack,71335-1720,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,07/01/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1720-2),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172501,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,10/23/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1725-1),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00054018813,bup,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203326,Hikma Pharmaceuticals USA Inc.,0054-0188,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,06/27/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (0054-0188-13),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00054018913,bup,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA203326,Hikma Pharmaceuticals USA Inc.,0054-0189,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,06/27/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (0054-0189-13),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
76420053430,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,"Asclemed USA, Inc.",76420-534,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,01/27/2023,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (76420-534-30)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
16729054910,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA209069,"Accord Healthcare, Inc",16729-549,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,01/22/2021,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (16729-549-10)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
16729055010,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,"Accord Healthcare, Inc",16729-550,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,01/22/2021,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (16729-550-10)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
00904700906,bup,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA203326,Major Pharmaceuticals,0904-7009,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,06/27/2014,N/A,ANDA,50 BLISTER PACK in 1 CARTON (0904-7009-06)  / 1 TABLET in 1 BLISTER PACK,"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
55700090130,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA207000,"Quality Care Products, LLC",55700-901,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (55700-901-30)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00406800503,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"2 mg/1,                         .5  mg/1",TABLET,SUBLINGUAL,ANDA207000,SpecGx LLC,0406-8005,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,12/13/2017,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (0406-8005-03)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
00406802003,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,SpecGx LLC,0406-8020,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,12/13/2017,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (0406-8020-03)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172500,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,42 TABLET in 1 BOTTLE (71335-1725-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172502,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,05/25/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1725-2),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172503,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1725-3),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172504,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1725-4),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172505,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,"14 TABLET in 1 BOTTLE, PLASTIC (71335-1725-5)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172506,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,"28 TABLET in 1 BOTTLE, PLASTIC (71335-1725-6)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172507,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,"6 TABLET in 1 BOTTLE, PLASTIC (71335-1725-7)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335185800,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"42 TABLET in 1 BOTTLE, PLASTIC (71335-1858-0)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335185801,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,05/07/2021,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (71335-1858-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
00904701006,bup,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA203326,Major Pharmaceuticals,0904-7010,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,06/27/2014,N/A,ANDA,50 BLISTER PACK in 1 CARTON (0904-7010-06)  / 1 TABLET in 1 BLISTER PACK,"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172508,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,"10 TABLET in 1 BOTTLE, PLASTIC (71335-1725-8)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335172509,bup,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA207000,Bryant Ranch Prepack,71335-1725,Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,"21 TABLET in 1 BOTTLE, PLASTIC (71335-1725-9)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
71335185802,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,06/08/2021,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (71335-1858-2)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335185803,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (71335-1858-3)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335185804,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"120 TABLET in 1 BOTTLE, PLASTIC (71335-1858-4)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335185805,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"14 TABLET in 1 BOTTLE, PLASTIC (71335-1858-5)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335185806,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"28 TABLET in 1 BOTTLE, PLASTIC (71335-1858-6)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335185807,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"6 TABLET in 1 BOTTLE, PLASTIC (71335-1858-7)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
71335185808,bup,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,"8 mg/1,                         2  mg/1",TABLET,SUBLINGUAL,ANDA209069,Bryant Ranch Prepack,71335-1858,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"10 TABLET in 1 BOTTLE, PLASTIC (71335-1858-8)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
47781040604,bup,buprenorphine transdermal system,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-406,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-406-04)  / 1 PATCH in 1 POUCH (47781-406-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
47781040704,bup,buprenorphine transdermal system,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-407,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-407-04)  / 1 PATCH in 1 POUCH (47781-407-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
47781040804,bup,buprenorphine transdermal system,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-408,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-408-04)  / 1 PATCH in 1 POUCH (47781-408-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
47781041904,bup,buprenorphine transdermal system,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-419,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-419-04)  / 1 PATCH in 1 POUCH (47781-419-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
58064040804,bup,buprenorphine transdermal system,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,"LTS Therapy Systems, LLC",58064-408,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (58064-408-04)  / 1 PATCH in 1 POUCH (58064-408-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
59011075004,bup,Butrans,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-750,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-750-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
59011075704,bup,Butrans,7.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-757,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-757-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
59011075204,bup,Butrans,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-752,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-752-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
59011075804,bup,Butrans,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-758,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-758-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
59011075104,bup,Butrans,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-751,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-751-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,0,NA
12496010001,bup,SUBLOCADE,100 mg/1,SOLUTION,SUBCUTANEOUS,NDA209819,Indivior Inc.,12496-0100,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/26/2018,N/A,NDA,1 POUCH in 1 CARTON (12496-0100-1)  / 1 SYRINGE in 1 POUCH (12496-0100-2)  / 1 SOLUTION in 1 SYRINGE (12496-0100-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
12496030001,bup,SUBLOCADE,300 mg/1,SOLUTION,SUBCUTANEOUS,NDA209819,Indivior Inc.,12496-0300,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/26/2018,N/A,NDA,1 POUCH in 1 CARTON (12496-0300-1)  / 1 SYRINGE in 1 POUCH (12496-0300-2)  / 1 SOLUTION in 1 SYRINGE (12496-0300-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
12496120203,bup,Suboxone,"2 mg/1,                         .5  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1202,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2010,N/A,NDA,"30 POUCH in 1 CARTON (12496-1202-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1202-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
12496120403,bup,Suboxone,"4 mg/1,                         1  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1204,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2012,N/A,NDA,"30 POUCH in 1 CARTON (12496-1204-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1204-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
12496120803,bup,Suboxone,"8 mg/1,                         2  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1208,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2010,N/A,NDA,"30 POUCH in 1 CARTON (12496-1208-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1208-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
12496121203,bup,Suboxone,"12 mg/1,                         3  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1212,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2012,N/A,NDA,"30 POUCH in 1 CARTON (12496-1212-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1212-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
54123011430,bup,Zubsolv,"11.4 mg/1,                         2.9  mg/1","TABLET, ORALLY DISINTEGRATING",SUBLINGUAL,NDA204242,"Orexo US, Inc.",54123-114,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/11/2014,N/A,NDA,"3 BLISTER PACK in 1 CARTON (54123-114-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
54123090730,bup,Zubsolv,".7 mg/1,                         .18  mg/1","TABLET, ORALLY DISINTEGRATING",SUBLINGUAL,NDA204242,"Orexo US, Inc.",54123-907,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/04/2013,N/A,NDA,"3 BLISTER PACK in 1 CARTON (54123-907-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
54123091430,bup,Zubsolv,"1.4 mg/1,                         .36  mg/1","TABLET, ORALLY DISINTEGRATING",SUBLINGUAL,NDA204242,"Orexo US, Inc.",54123-914,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/04/2013,N/A,NDA,"3 BLISTER PACK in 1 CARTON (54123-914-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
54123092930,bup,Zubsolv,"2.9 mg/1,                         .71  mg/1","TABLET, ORALLY DISINTEGRATING",SUBLINGUAL,NDA204242,"Orexo US, Inc.",54123-929,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/04/2013,N/A,NDA,"3 BLISTER PACK in 1 CARTON (54123-929-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
54123095730,bup,Zubsolv,"5.7 mg/1,                         1.4  mg/1","TABLET, ORALLY DISINTEGRATING",SUBLINGUAL,NDA204242,"Orexo US, Inc.",54123-957,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/04/2013,N/A,NDA,"3 BLISTER PACK in 1 CARTON (54123-957-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
54123098630,bup,Zubsolv,"8.6 mg/1,                         2.1  mg/1","TABLET, ORALLY DISINTEGRATING",SUBLINGUAL,NDA204242,"Orexo US, Inc.",54123-986,buprenorphine hydrochloride and naloxone hydrochloride,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/11/2014,N/A,NDA,"3 BLISTER PACK in 1 CARTON (54123-986-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,0,NA
